Ernexa Therapeutics Inc. Stock Issued During Period, Shares, Reverse Stock Splits
Ernexa Therapeutics Inc. (ERNA) had Stock Issued During Period, Shares, Reverse Stock Splits of 1.51 million shares as of 2021-03-25, per its 10-K/A filed 2022-07-01.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits · last filed 2022-07-01
- 2021-03-25: Stock Issued During Period, Shares, Reverse Stock Splits 1.51M shares; Stock Issued During Period, Shares, Reverse Stock Splits as first filed 1.51M shares.
| Period end | Stock Issued During Period, Shares, Reverse Stock Splits | Stock Issued During Period, Shares, Reverse Stock Splits as first filed |
|---|---|---|
| 2021-03-25 | 1.51M shares 10-K/A · filed 2022-07-01 | 1.51M shares 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |